Mike Smith Email Address

Chief Financial Officer

Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

Over 20 years in senior executive busness and general management roles at publicly-traded (NASDAQ: ZGNX/RPTP/MEMY/QLTI/CHIR) and private biotechnology companies including Chief Financial Officer, Chief Business Officer and General Manager of operating divisions. Track record of success in developing and driving business strategies and operations, deal making and overseeing company turnarounds in high pressure environments. Operations leadership in finance, project management, sales, marketing, corporate development, Wall Street investor relations, intellectual property and strategic alliances. Managed and led over $4+B of transactions including public company equity and debt financings, product and company acquisitions, and strategic licenses and partnerships.